Inhibitors of the hedgehog pathway
The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Fo...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.08.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer. |
---|---|
Bibliography: | Application Number: US201213487559 |